This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (17)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Nutritional and Metabolic Disorders, Other  • Aging/ Geriatrics  • Alert me on articles by topic

A Dose-Finding Trial

Simone J. P. M. Eussen, MSc; Lisette C. P. G. M. de Groot, PhD; Robert Clarke, MD; Jörn Schneede, MD; Per M. Ueland, MD; Willibrord H. L. Hoefnagels, MD, PhD; Wija A. van Staveren, PhD

Arch Intern Med. 2005;165:1167-1172.

Background  Supplementation with high doses of oral cobalamin is as effective as cobalamin administered by intramuscular injection to correct plasma markers of vitamin B₁₂ deficiency, but the effects of lower oral doses of cobalamin on such markers are uncertain.

Methods  We conducted a randomized, parallel-group, double-blind, dose-finding trial to determine the lowest oral dose of cyanocobalamin required to normalize biochemical markers of vitamin B₁₂ deficiency in older people with mild vitamin B₁₂ deficiency, defined as a serum vitamin B₁₂ level of 100 to 300 pmol/L (135-406 pg/mL) and a methylmalonic acid level of 0.26 µmol/L or greater. We assessed the effects of daily oral doses of 2.5, 100, 250, 500, and 1000 µg of cyanocobalamin administered for 16 weeks on biochemical markers of vitamin B₁₂ deficiency in 120 people. The main outcome measure was the dose of oral cyanocobalamin that produced 80% to 90% of the estimated maximal reduction in the plasma methylmalonic acid concentration.

Results  Supplementation with cyanocobalamin in daily oral doses of 2.5, 100, 250, 500, and 1000 µg was associated with mean reductions in plasma methylmalonic acid concentrations of 16%, 16%, 23%, 33%, and 33%, respectively. Daily doses of 647 to 1032 µg of cyanocobalamin were associated with 80% to 90% of the estimated maximum reduction in the plasma methylmalonic acid concentration.

Conclusion  The lowest dose of oral cyanocobalamin required to normalize mild vitamin B₁₂ deficiency is more than 200 times greater than the recommended dietary allowance, which is approximately 3 µg daily.

Author Affiliations: Division of Human Nutrition, Wageningen University, Wageningen, the Netherlands (Ms Eussen and Drs de Groot and van Staveren); Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, England (Dr Clark); LOCUS of Homocysteine and Related Vitamins, University of Bergen, Bergen, Norway (Drs Schneede and Ueland); and Department of Geriatrics, Hospital St Radboud, Nijmegen, the Netherlands (Dr Hoefnagels).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Homocysteine and Folate Status in an Era of Folic Acid Fortification: Balancing Benefits, Risks, and B-vitamins
Ueland and Hustad
Clin. Chem. 2008;54:779-781.
FULL TEXT  

Low vitamin B-12 status and risk of cognitive decline in older adults
Clarke et al.
Am. J. Clin. Nutr. 2007;86:1384-1391.
ABSTRACT | FULL TEXT  

Effect of a voluntary food fortification policy on folate, related B vitamin status, and homocysteine in healthy adults
Hoey et al.
Am. J. Clin. Nutr. 2007;86:1405-1413.
ABSTRACT | FULL TEXT  

Evidence-based decision making on micronutrients and chronic disease: long-term randomized controlled trials are not enough
Ames et al.
Am. J. Clin. Nutr. 2007;86:522-523.
FULL TEXT  

Very Low Oral Doses of Vitamin B-12 Increase Serum Concentrations in Elderly Subjects with Food-Bound Vitamin B-12 Malabsorption
Blacher et al.
J. Nutr. 2007;137:373-378.
ABSTRACT | FULL TEXT  

Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage
Ames
Proc. Natl. Acad. Sci. USA 2006;103:17589-17594.
ABSTRACT | FULL TEXT  

Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial.
Eussen et al.
Am. J. Clin. Nutr. 2006;84:361-370.
ABSTRACT | FULL TEXT  

Clinical relevance of low serum vitamin B12 concentrations in older people: the Banbury B12 study
Hin et al.
Age Ageing 2006;35:416-422.
ABSTRACT | FULL TEXT  

Effect of Vitamin B12 Treatment on Haptocorrin
Morkbak et al.
Clin. Chem. 2006;52:1104-1111.
ABSTRACT | FULL TEXT  

Review: limited evidence from 2 randomised controlled trials suggests that oral and intramuscular vitamin B12 have similar effectiveness for vitamin B12 deficiency
Bial
Evid. Based Med. 2006;11:9-9.
FULL TEXT